Program overview
Context
Indication: Advanced/Metastatic Solid Tumors
Mechanism: Unknown
Modality: Unknown
Sponsor: Qilu Pharmaceutical Co., .
Watchlist Signal
MHB088C for Injection
MHB088C for Injection is flagged as watchlist signal because public records show timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 1/5
Timeline: 2/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 2/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT07102004 | https://clinicaltrials.gov/study/NCT05652855
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT07102004 | Low Signal (RECRUITING) | long_recruitment_duration_signal | Low Signal | large_enrollment_target_signal | few_sites_large_trial_signal |
| NCT05652855 | Low Signal (NOT_YET_RECRUITING) | stale_update_signal | long_recruitment_duration_signal | Low Signal | rare_population_signal | strict_eligibility_signal |